Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcutis Biotherapeutics (ARQT) Gains from Investment Securities: 2019-2020

Historic Gains from Investment Securities for Arcutis Biotherapeutics (ARQT) over the last 2 years, with Dec 2020 value amounting to $3.6 million.

  • Arcutis Biotherapeutics' Gains from Investment Securities rose 754.29% to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.3 million, marking a year-over-year change of. This contributed to the annual value of $3.6 million for FY2020, which is 825.06% up from last year.
  • Per Arcutis Biotherapeutics' latest filing, its Gains from Investment Securities stood at $3.6 million for FY2020, which was up 825.06% from $391,000 recorded in FY2019.
  • Arcutis Biotherapeutics' 5-year Gains from Investment Securities high stood at $3.6 million for FY2020, and its period low was $391,000 during FY2019.
  • In the last 2 years, Arcutis Biotherapeutics' Gains from Investment Securities had a median value of $2.0 million in 2019 and averaged $2.0 million.
  • Data for Arcutis Biotherapeutics' Gains from Investment Securities shows a peak YoY skyrocketed of 825.06% (in 2020) over the last 5 years.
  • Arcutis Biotherapeutics' Gains from Investment Securities (Yearly) stood at $391,000 in 2019, then surged by 825.06% to $3.6 million in 2020.